During early development of biologics, there are a large number of attributes researchers evaluate, but some of the most common center around stability – asking if a biologic is well-folded, active, and pure in its buffer, and whether it remains that way over time.
Biophysical characterization measurements from nanoDSF, DLS, backreflection, and SLS are valuable for providing this information without using a lot of material.
Read more to see how each of these technologies is helpful for characterization of your candidates during biologic development prior to clinical trials.
To learn more about tools for stability assessment of biologics, discover Prometheus Panta.
